Julia Karbach

8.9k citations

97 papers · 6.1k indexed · 3 hit papers · h-index 36

Impact in

Immunology top 0.2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in ⓘ

Immunology 66
- Immunotherapy and Immune Responses 62
- T-cell and B-cell Immunology 31
- Immune Cell Function and Interaction 17
Oral Surgery 8

Co-authors: Elke Jäger (60 shared papers)Alexander Knuth (38 shared papers)Michael Arand (16 shared papers)Lloyd J. Old (22 shared papers)Elisabeth Stockert (10 shared papers)Mark Ringhoffer (8 shared papers)Yao‐Tseng Chen (8 shared papers)Dirk Jäger (9 shared papers)
Journals: International Journal of Cancer (16 papers)Journal of Clinical Oncology (7 papers)Proceedings of the National Academy of Sciences (5 papers)Clinical Cancer Research (4 papers)Cancer Research (4 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Julia Karbach

90 papers receiving 6.0k citations

Hit Papers

align trajectories log scale

Anti-CCR4 mAb selectively depletes effector-type FoxP3⁺CD4⁺regulatory T cells, evoking antitumor immune responses in humans 2013 · 505 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Proceedings of the National Academy of Sciences
1998 The Journal of Experimental Medicine
1998 The Journal of Experimental Medicine

Peers

Countries citing papers authored by Julia Karbach

Since Specialization

Citations

This map shows the geographic impact of Julia Karbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Karbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Karbach more than expected).

Fields of papers citing papers by Julia Karbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Karbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Karbach. The network helps show where Julia Karbach may publish in the future.

Co-authors

The 25 scholars most cited alongside Julia Karbach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Julia Karbach Line = papers co-authored together Julia Karbach links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes The Journal of Experimental Medicine ·Elke Jäger, Yao-Tseng Chen, Jan W. Drijfhout, Julia Karbach, Mark Ringhoffer, Dirk Jäger, Michael Arand, Hisashi Wada, Yuji Noguchi, Elisabeth Stockert, Lloyd J. Old, Alexander Knuth Hit paper breakdown →	1998	594
2	A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens The Journal of Experimental Medicine ·Elisabeth Stockert, Elke Jäger, Yao‐Tseng Chen, Matthew J. Scanlan, Ivan Gout, Julia Karbach, Michael Arand, Alexander Knuth, Lloyd J. Old Hit paper breakdown →	1998	593
3	Anti-CCR4 mAb selectively depletes effector-type FoxP3⁺CD4⁺regulatory T cells, evoking antitumor immune responses in humans Proceedings of the National Academy of Sciences ·Daisuke Sugiyama, Hiroyoshi Nishikawa, Yuka Maeda, Megumi Nishioka, Atsushi Tanemura, Ichiro Katayama, Sachiko Ezoe, Yuzuru Kanakura, Eiichi Sato, Yasuo Fukumori, Julia Karbach, Elke Jäger, Shimon Sakaguchi Hit paper breakdown →	2013	505
4	Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers Proceedings of the National Academy of Sciences ·Elke Jäger, Sacha Gnjatic, Yasuhiro Nagata, Elisabeth Stockert, Dirk Jäger, Julia Karbach, Antje Neumann, Julia Rieckenberg, Yao‐Tseng Chen, Gerd Ritter, Eric W. Hoffman, Michael Arand, Lloyd J. Old, Alexander Knuth	2000	363
5	Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses Proceedings of the National Academy of Sciences ·Elke Jäger, Yasuhiro Nagata, Sacha Gnjatic, Hisashi Wada, Elisabeth Stockert, Julia Karbach, P. Rod Dunbar, Sang Yull Lee, Achim A. Jungbluth, Dirk Jäger, Michael Arand, Gerd Ritter, Vincenzo Cerundolo, Bo Dupont, Yao‐Tseng Chen, Lloyd J. Old, Alexander Knuth	2000	337
6	Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma International Journal of Cancer ·Elke Jäger, Mark Ringhoffer, M. Altmannsberger, Michael Arand, Julia Karbach, Dirk Jäger, Franz Oesch, Alexander Knuth	1997	256
7	Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptidesin vivo International Journal of Cancer ·Elke J�ger, Mark Ringhoffer, Hans Peter Dienes, Michael Arand, Julia Karbach, Dirk J�ger, Christiane Ilsemann, Manfred Hagedorn, Franz Oesch, Alexander Knuth	1996	246
8	Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: Evidence for immunoselection of antigen-loss variantsin vivo International Journal of Cancer ·Elke Jäger, Mark Ringhoffer, Julia Karbach, Michael Arand, Franz Oesch, Alexander Knuth	1996	218
9	Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptidesin vivo: Implications for tumor vaccines with melanoma-associated antigens International Journal of Cancer ·E. Jaeger, Helga Bernhard, Pedro Romero, Mark Ringhoffer, Michael Arand, Julia Karbach, Christiane Ilsemann, Manfred Hagedorn, Alexander Knuth	1996	195
10	Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb40101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma The Journal of Experimental Medicine* ·Elke Jäger, Dirk Jäger, Julia Karbach, Yao‐Tseng Chen, Gerd Ritter, Yasuhiro Nagata, Sacha Gnjatic, Elisabeth Stockert, Michael Arand, Lloyd J. Old, Alexander Knuth	2000	186
11	Humoral immune responses of cancer patients against “Cancer-Testis” antigen NY-ESO-1: Correlation with clinical events International Journal of Cancer ·Elke Jäger, Elisabeth Stockert, Zacharias Zidianakis, Yao‐Tseng Chen, Julia Karbach, Dirk Jäger, Michael Arand, Gerd Ritter, Lloyd J. Old, Alexander Knuth	1999	182
12	Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients Proceedings of the National Academy of Sciences ·Elke Jäger, Julia Karbach, Sacha Gnjatic, Antje Neumann, Armin Bender, Danila Valmori, Maha Ayyoub, Erika Ritter, Gerd Ritter, Dirk Jäger, Dennis Panicali, Eric W. Hoffman, Linda Pan, Herbert F. Oettgen, Lloyd J. Old, Alexander Knuth	2006	172
13	Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients Proceedings of the National Academy of Sciences ·Kunle Odunsi, Junko Matsuzaki, Julia Karbach, Antje Neumann, Paulette Mhawech‐Fauceglia, Austin Miller, Amy Beck, Carl D. Morrison, Gerd Ritter, Heidi Godoy, Shashikant Lele, Nefertiti C. duPont, Robert P. Edwards, Protul Shrikant, Lloyd J. Old, Sacha Gnjatic, Elke Jäger	2012	148
14	The DNA demethylating agent 5-aza-2′-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells Leukemia Research ·Maika Almstedt, Nadja Blagitko‐Dorfs, Jesús Duque‐Afonso, Julia Karbach, Dietmar Pfeifer, Elke Jäger, Michael Lübbert	2010	147
15	Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. PubMed ·Dirk Jäger, Elisabeth Stockert, Ali O. Güre, Matthew J. Scanlan, Julia Karbach, Elke Jäger, Alexander Knuth, Lloyd J. Old, Yu‐Hsien Chen	2001	117
16	Tumor‐reactive CD8⁺ T‐cell responses after vaccination with NY‐ESO‐1 peptide, CpG 7909 and Montanide® ISA‐51: association with survival International Journal of Cancer ·Julia Karbach, Sacha Gnjatic, Armin Bender, Antje Neumann, Eckhart Weidmann, Jianda Yuan, Cathy A. Ferrara, Eric W. Hoffmann, Lloyd J. Old, Nasser K. Altorki, Elke Jäger	2009	100
17	A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial Clinical Cancer Research ·Matthias Kloor, Miriam Reuschenbach, Claudia Pauligk, Julia Karbach, Mohammad‐Reza Rafiyan, Salah‐Eddin Al‐Batran, Mirjam Tariverdian, Elke Jäger, Magnus von Knebel Doeberitz	2020	92
18	Clonal expansion of melan a-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides International Journal of Cancer ·Elke J�ger, Markus Maeurer, Hanni H�hn, Julia Karbach, Dirk J�ger, Zacharias Zidianakis, Afsaneh Bakhshandeh‐Bath, Jaqueline Orth, Claudia Neukirch, Antje Necker, Torsten E. Reichert, Alexander Knuth	2000	88
19	Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity Clinical Cancer Research ·Julia Karbach, Antje Neumann, Kathrin Brand, Claudia Wahle, Ekkehard Siegel, Markus Maeurer, Erika Ritter, Takamasa Tsuji, Sacha Gnjatic, Lloyd J. Old, Gerd Ritter, Elke Jäger	2012	79
20	Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors The Journal of Immunology ·Marco A. Purbhoo, Deborah H. Sutton, Joanna E. Brewer, Rebecca E. Mullings, Maxine E. Hill, Tara Mahon, Julia Karbach, Elke Jäger, Brian Cameron, Nikolai M. Lissin, Paresh Vyas, Ji‐Li Chen, Vincenzo Cerundolo, Bent K. Jakobsen	2006	74

About Julia Karbach

Julia Karbach is a scholar working on Immunology, Oral Surgery, Oncology, Biotechnology and Otorhinolaryngology, having authored 97 papers that have together received 6.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (62 papers), T-cell and B-cell Immunology (31 papers), vaccines and immunoinformatics approaches (22 papers), Immune Cell Function and Interaction (17 papers), CAR-T cell therapy research (16 papers), Cancer Immunotherapy and Biomarkers (13 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Virus-based gene therapy research (8 papers). The work is most often cited by research in Immunology (4.8k citations), Oncology (2.4k citations), Molecular Biology (2.6k citations), Radiology, Nuclear Medicine and Imaging (788 citations) and Periodontics (118 citations). Julia Karbach has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Elke Jäger, Alexander Knuth, Michael Arand, Lloyd J. Old, Elisabeth Stockert, Mark Ringhoffer, Yao‐Tseng Chen, Dirk Jäger, Gerd Ritter and Sacha Gnjatic. Their work appears in journals such as International Journal of Cancer, Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, Clinical Cancer Research and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact